FATE THERAPEUTICS INC (FATE) Stock Institutional Trading Activity


FATE THERAPEUTICS INC (FATE) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, ARK Invest, and Lone Pine Capital. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCBuy1,098,3662,360,881$2,319,802
Q3 2025Renaissance Technologies LLCBuy1,048,0521,262,515$1,590,769
Q2 2025Renaissance Technologies LLCSell-164,156214,463$240,199
Q4 2024Renaissance Technologies LLCBuy16,000378,619$624,721
Q3 2024Renaissance Technologies LLCSell-185,925362,619$1,269,167
Q2 2024Renaissance Technologies LLCBuy439,325548,544$1,799,224
Q3 2023Renaissance Technologies LLCSell-563,097109,219$232
Q2 2023Renaissance Technologies LLCSell-660,603672,316$3,200
Q1 2023Renaissance Technologies LLCSell-472,0171,332,919$7,598
Q4 2022ARK InvestSell-7,440,9704,214,863$42,527,968
Q4 2022Renaissance Technologies LLCBuy1,267,4171,804,936$18,212
Q3 2022ARK InvestBuy182,17811,655,833$261,207
Q3 2022Renaissance Technologies LLCBuy492,200537,519$12,046
Q2 2022ARK InvestBuy485,47311,473,655$265,041
Q1 2022ARK InvestBuy676,01510,988,182$426,012
Q1 2022Renaissance Technologies LLCBuy10,60045,319$1,757
Q4 2021ARK InvestSell-590,09110,312,167$603,365
Q3 2021ARK InvestBuy3,419,15610,902,258$646,177
Q3 2021Lone Pine CapitalBuy450,0002,199,284$130,352
Q2 2021ARK InvestBuy928,5567,483,102$649,458
Q2 2021Renaissance Technologies LLCSell-16,90034,719$3,013
Q1 2021ARK InvestBuy3,652,8466,554,546$540,422
Q1 2021Lone Pine CapitalBuy865,6181,749,284$144,228
Q4 2020ARK InvestBuy1,461,7302,901,700$263,852
Q4 2020Lone Pine CapitalBuy883,666883,666$80,352
Q3 2020ARK InvestBuy420,1401,439,970$57,556
Q3 2020Renaissance Technologies LLCBuy39,80051,619$2,063
Q2 2020ARK InvestBuy464,7481,019,830$34,990
Q1 2020ARK InvestBuy123,954555,082$12,328
Q4 2019ARK InvestBuy92,089431,128$8,437

Frequently asked questions about FATE activity

  • Which institutional owners are buying FATE?

    Institutional owners buying FATE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in FATE activity?

    "Buy" means an investor increased their reported position in FATE compared to the prior reporting period. This reflects growing exposure to FATE THERAPEUTICS INC (FATE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in FATE increasing?

    Institutional interest in FATE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.